Skip to content

Clinical trials

Hepatitis C trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Country / region: Israel Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20062
20073
20082
20093
20101
20114
20124
20132
20141
20172
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Unknown status6
Terminated2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
AbbVie3
Human Genome Sciences Inc.3
GlaxoSmithKline2
Janssen R&D Ireland2
Meridian Bioscience, Inc.2
Ziv Hospital2
Assy Nimer1
Bausch Health Americas, Inc.1
Can-Fite BioPharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C30
Hepatitis C, Chronic11
Fibrosis3
Hepatitis2
Acidosis, Lactic1
Acquired Immunodeficiency Syndrome1
Anemia, Sickle Cell1
Carcinoma, Hepatocellular1
Cardiovascular Diseases1
Coinfection1

Trials

Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.